Follow-up Recommendations for Individuals Immune to Measles and Mumps but Not Rubella
For individuals who are immune to measles and mumps but lack immunity to rubella, a single dose of MMR vaccine should be administered to achieve complete immunity against all three diseases.1, 2
Understanding the Importance of Rubella Immunity
Rubella immunity is particularly critical for several reasons:
- Rubella infection during pregnancy can lead to Congenital Rubella Syndrome (CRS), which can cause severe birth defects
- Even asymptomatic rubella infections can transmit the virus to susceptible individuals
- Complete immunity to all three diseases (measles, mumps, and rubella) provides optimal protection for both the individual and community
Recommended Management Algorithm
Confirm immunity status:
- Verify that serologic testing confirms immunity to measles and mumps but not rubella
- No additional laboratory testing is needed before vaccination 1
Administer MMR vaccine:
Post-vaccination considerations:
Special Population Considerations
For Healthcare Workers
- Healthcare workers without rubella immunity should receive MMR vaccination promptly
- This is particularly important for female healthcare workers of childbearing age 1
- During rubella outbreaks in healthcare settings, vaccination is strongly recommended regardless of birth year 1
For Women of Childbearing Age
- Women should avoid pregnancy for 28 days after receiving MMR vaccine 3
- Rubella immunity is especially important before pregnancy to prevent congenital rubella syndrome 1
For International Travelers
- Complete MMR immunity is strongly recommended before international travel 1
- Travelers without rubella immunity should be vaccinated at least 2 weeks before departure 1
Important Caveats and Considerations
- Contraindications: Do not administer MMR vaccine to pregnant women, severely immunocompromised individuals, or those with severe allergic reactions to vaccine components 1
- Timing with immune globulin: If the individual has recently received immune globulin, MMR vaccination should be delayed according to the specific interval recommended based on the product and dose received 1
- No need for immune globulin after exposure: Unlike measles, immune globulin is not effective for post-exposure prophylaxis against rubella 1
Effectiveness of MMR Vaccination
Research shows that a single dose of MMR vaccine produces rubella immunity in approximately 95% of recipients, which is higher than the response rates for measles and mumps components 4. After a second dose of MMR, the proportion of individuals negative to one or more antigens drops to less than 4% 4.
The MMR vaccine has demonstrated robust immune responses even when administered to individuals who already have immunity to one or more components, with no increased risk of adverse events 5.